# Rhythm Pharmaceuticals, Inc. (RYTM)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RYTM/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 60.11M | $ -55.64M | $ -44.19M | $ 227.02M | $ 122.91M |
| 2025 | $ 194.29M | $ -201.24M | $ -119.42M | $ 246.47M | $ 139.07M |
| 2024 | $ 136.77M | $ -273.88M | $ -161.74M | $ 3.94M | $ 164.55M |
| 2023 | $ 83.72M | $ -199.68M | $ -148.22M | $ 1.26M | $ 169.76M |
| 2022 | $ 26.41M | $ -202.33M | $ -198.52M | $ 1.94M | $ 264.26M |
| 2021 | $ 3.75M | $ -82.74M | $ -180.01M | $ 2.55M | $ 284.15M |
| 2020 | $ 0 | $ -170.70M | $ -155.67M | $ 3.09M | $ 166.53M |
| 2019 | $ 0 | $ -181.65M | $ -162.81M | $ 3.56M | $ 281.02M |
| 2018 | $ 0 | $ -97.82M | $ -82.91M | $ 0 | $ 246.26M |
| 2017 | $ 0 | $ -45.41M | $ -39.87M | $ 0 | $ 144.79M |
| 2016 | $ 0 | $ -37.79M | $ -33.40M | $ 0 | $ 7.30M |
| 2015 | $ 0 | $ -16.85M | $ -9.82M | $ 0 | $ 32.00M |
| 2014 | $ 0 | $ -9.17M | $ -10.61M | $ 0 | $ -358.0K |
| 2013 | N/A | N/A | N/A | $ 0 | $ -57.46M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 1.85 |
| Liabilities / Eq | 2.60 |
| Current Ratio | 4.17 |

## Other views

- [Metrics](https://sponda.capital/en/RYTM.md)
- [Charts](https://sponda.capital/en/RYTM/charts.md)
- [Compare](https://sponda.capital/en/RYTM/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.